Applied Therapeutics, Inc.
APLT
$0.441
-$0.0191-4.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -68.59M | 2.90M | -83.94M | -37.68M | -42.37M |
| Total Depreciation and Amortization | 104.00K | 122.00K | 120.00K | 6.00K | 118.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.17M | -20.80M | 66.04M | 18.97M | 29.38M |
| Change in Net Operating Assets | 2.99M | -4.81M | -1.14M | 1.70M | -1.85M |
| Cash from Operations | -23.33M | -22.60M | -18.91M | -17.01M | -14.73M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -311.00K | -465.00K | -465.00K |
| Issuance of Common Stock | 0.00 | -- | 115.81M | 29.91M | 17.03M |
| Repurchase of Common Stock | -- | -1.69M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 0.00 | -1.69M | 115.50M | 29.45M | 16.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.33M | -24.29M | 96.59M | 12.44M | 1.84M |
